These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27879479)

  • 1. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
    Bing ZT; Yang GH; Xiong J; Guo L; Yang L
    IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma.
    Xiao Y; Ping Y; Fan H; Xu C; Guan J; Zhao H; Li Y; Lv Y; Jin Y; Wang L; Li X
    Neuro Oncol; 2013 Jul; 15(7):818-28. PubMed ID: 23516263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
    Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
    BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
    Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
    Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
    Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
    J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
    Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
    Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma.
    Sun J; Gong X; Purow B; Zhao Z
    PLoS Comput Biol; 2012; 8(7):e1002488. PubMed ID: 22829753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme.
    Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S
    World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
    Yerukala Sathipati S; Huang HL; Ho SY
    BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
    Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
    Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.
    Xiong J; Bing Z; Su Y; Deng D; Peng X
    PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.
    Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y
    J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of gene expression profiles to diagnose crucial and novel genes in glioblastoma multiform.
    Vastrad C; Vastrad B
    Pathol Res Pract; 2018 Sep; 214(9):1395-1461. PubMed ID: 30097214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
    Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
    Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.